EMILY HEISHMAN: Open Payments
NPI 1114478658 · MILFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 13 payments from 7 companies in 2025. Trend: 2023 $23 · 2024 $110 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $166 |
| ABBVIE INC. | 4 | $143 |
| Xeris Pharmaceuticals, Inc. | 1 | $135 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Novo Nordisk Inc | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $106 |
| KYOWA KIRIN, INC. | 1 | $104 |
Products named: CAPLYTA, VRAYLAR, GVOKE HYPOPEN, VOQUEZNA, Wegovy, AUSTEDO XR, CRYSVITA.
Industry payments across DE — which companies pay providers there.
